Business Description
Apyx Medical Corp
NAICS : 339112
SIC : 3841
ISIN : US10211F1003
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.13 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.44 | |||||
Debt-to-EBITDA | -2.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.34 | |||||
Beneish M-Score | -3.97 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.1 | |||||
3-Year EBITDA Growth Rate | 1.1 | |||||
3-Year EPS without NRI Growth Rate | -14.8 | |||||
3-Year FCF Growth Rate | 30 | |||||
3-Year Book Growth Rate | -25.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.86 | |||||
9-Day RSI | 36.15 | |||||
14-Day RSI | 38.05 | |||||
6-1 Month Momentum % | -28.07 | |||||
12-1 Month Momentum % | -39.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.52 | |||||
Quick Ratio | 4.74 | |||||
Cash Ratio | 3.43 | |||||
Days Inventory | 216.44 | |||||
Days Sales Outstanding | 82.71 | |||||
Days Payable | 47.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -38.51 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 64.49 | |||||
Operating Margin % | -38.11 | |||||
Net Margin % | -35.75 | |||||
FCF Margin % | -10.91 | |||||
ROE % | -54.95 | |||||
ROA % | -30.21 | |||||
ROIC % | -59.19 | |||||
ROC (Joel Greenblatt) % | -83.01 | |||||
ROCE % | -39.63 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.92 | |||||
PB Ratio | 1.8 | |||||
Price-to-Tangible-Book | 1.82 | |||||
EV-to-EBIT | -2.29 | |||||
EV-to-EBITDA | -2.37 | |||||
EV-to-Revenue | 0.82 | |||||
EV-to-FCF | -7.44 | |||||
Price-to-Median-PS-Value | 0.2 | |||||
Price-to-Net-Current-Asset-Value | 2.74 | |||||
Earnings Yield (Greenblatt) % | -43.67 | |||||
FCF Yield % | -12.01 | |||||
Forward Rate of Return (Yacktman) % | 10.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Apyx Medical Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 48.532 | ||
EPS (TTM) (€) | -0.5 | ||
Beta | -0.66 | ||
Volatility % | 118.77 | ||
14-Day RSI | 38.05 | ||
14-Day ATR (€) | 0.07472 | ||
20-Day SMA (€) | 1.2865 | ||
12-1 Month Momentum % | -39.26 | ||
52-Week Range (€) | 1.09 - 6.95 | ||
Shares Outstanding (Mil) | 34.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Apyx Medical Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Apyx Medical Corp Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Apyx Medical Corp Frequently Asked Questions
What is Apyx Medical Corp(FRA:BOV)'s stock price today?
When is next earnings date of Apyx Medical Corp(FRA:BOV)?
Does Apyx Medical Corp(FRA:BOV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |